Yohei Kume
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yohei Kume has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Koichi Hashimoto
Department of Pediatrics Fukushima Medical University School of Medicine Fukushima Japan
11 shared publications - Mitsuaki Hosoya
Department of Pediatrics Fukushima Medical University School of Medicine Fukushima Japan
10 shared publications Hayato Go
Department of Pediatrics Fukushima Medical University School of Medicine Fukushima Japan
9 shared publicationsKazuhide Suyama
Department of Pediatrics Fukushima Medical University School of Medicine Fukushima Japan
8 shared publicationsMitsuaki Hosoya
Department of Pediatrics School of Medicine, Fukushima Medical University Fukushima Japan
7 shared publicationsHiroko Sakuma
Department of Pediatrics Hoshi General Hospital Koriyama Fukushima Japan
5 shared publications
Latest Publications
- Open Access
- 12 May 2026
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 75 (5) , 002165
Temporal genetic changes in human bocavirus 1 in Fukushima, Japan, from 2018 to 2024
Introduction. Human bocavirus 1 (HBoV1) is a member of Bocaparvovirus primate1 and is associated with paediatric respiratory infections. Although genetic grouping has been described, it remains unclear whether temporal genetic changes occur among clinically circulating HBoV1 strains. Hypothesis/Gap Statement. HBoV1 shows limited genetic diversity, but temporal genetic changes may occur in circulating strains. Aim. To investigate whether temporal genetic changes are present in HBoV1 isolates collected in Fukushima, Japan, between 2018 and 2024. Methodology. Nasopharyngeal swabs were collected from paediatric inpatients with acute respiratory infections. Thirty-two HBoV1 isolates were obtained using air–liquid interface cultures of human bronchial/tracheal epithelial cells. Nearly complete genomes were sequenced by next-generation sequencing and analysed together with additional reference sequences (total n =100, including outgroups) using phylogenetic and time-scaled methods. Results. Phylogenetic analyses classified the 32 Fukushima isolates into Group 1 ( n =12) and Group 2 ( n =20). Group 2 predominated in 2018, Group 1 from 2019 to 2021 and Group 2 again from 2022 to 2024, indicating temporal shifts in circulating strains. The average number of nucleotide differences among HBoV1 genomes was 13.9 (maximum 55), with Groups 1 and 2 diverging around 2004–2005. Divergence was concentrated in the VP genes, and synonymous substitutions within VP genes overlapped the ORFx reading frame, leading to distinct amino acid differences in ORFx. Conclusion. Clinically circulating HBoV1 undergoes temporal genetic change, with group differentiation determined primarily by VP genes and uniquely by ORFx at the amino acid level. These findings suggest a potential biological role for ORFx in the HBoV1 life cycle. Understanding these temporal genetic shifts is important for enhancing the accuracy of molecular surveillance tools, particularly for distinguishing genetically diverse HBoV1 strains.
- 12 May 2026
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 75 (5) , 002165
Open AccessTemporal genetic changes in human bocavirus 1 in Fukushima, Japan, from 2018 to 2024
Introduction. Human bocavirus 1 (HBoV1) is a member of Bocaparvovirus primate1 and is associated with paediatric respiratory infections. Although genetic grouping has been described, it remains unclear whether temporal genetic changes occur among clinically circulating HBoV1 strains. Hypothesis/Gap Statement. HBoV1 shows limited genetic diversity, but temporal genetic changes may occur in circulating strains. Aim. To investigate whether temporal genetic changes are present in HBoV1 isolates collected in Fukushima, Japan, between 2018 and 2024. Methodology. Nasopharyngeal swabs were collected from paediatric inpatients with acute respiratory infections. Thirty-two HBoV1 isolates were obtained using air–liquid interface cultures of human bronchial/tracheal epithelial cells. Nearly complete genomes were sequenced by next-generation sequencing and analysed together with additional reference sequences (total n =100, including outgroups) using phylogenetic and time-scaled methods. Results. Phylogenetic analyses classified the 32 Fukushima isolates into Group 1 ( n =12) and Group 2 ( n =20). Group 2 predominated in 2018, Group 1 from 2019 to 2021 and Group 2 again from 2022 to 2024, indicating temporal shifts in circulating strains. The average number of nucleotide differences among HBoV1 genomes was 13.9 (maximum 55), with Groups 1 and 2 diverging around 2004–2005. Divergence was concentrated in the VP genes, and synonymous substitutions within VP genes overlapped the ORFx reading frame, leading to distinct amino acid differences in ORFx. Conclusion. Clinically circulating HBoV1 undergoes temporal genetic change, with group differentiation determined primarily by VP genes and uniquely by ORFx at the amino acid level. These findings suggest a potential biological role for ORFx in the HBoV1 life cycle. Understanding these temporal genetic shifts is important for enhancing the accuracy of molecular surveillance tools, particularly for distinguishing genetically diverse HBoV1 strains.
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1)
Pneumococcal Serotypes Isolated From Invasive Infections in Children in Fukushima Prefecture From 2016 to 2025
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1)
Pneumococcal Serotypes Isolated From Invasive Infections in Children in Fukushima Prefecture From 2016 to 2025
- 11 February 2025
- Published by Wiley in Microbiology and Immunology
- Vol. 69 (4) , 220-228
A Clinical Isolate of Human Parainfluenza Virus 3 (Fukushima/O695/2019) Contains a Mutation in the Serial Guanosines in the RNA Editing Site of the P Gene and Produces an Atypical Number of Nongenomic Guanosine Insertions During RNA Editing
Human parainfluenza virus 3 (HPIV3) contains a purine‐rich RNA editing site, allowing multiple viral proteins to be produced from a single gene by the posttranscriptional addition of G nucleotides. The Fukushima/O695/2019 (O695) HPIV3 clinical isolate has a G‐to‐A substitution at the last position of five serial G residues in the RNA editing site. This study evaluates the effects of this substitution in the RNA editing site on the biological character of HPIV3. Our results show that O695 has slightly reduced viral replication compared with viruses with an intact RNA editing site. The number of G nucleotides inserted into the RNA editing site in HPIV3 isolates with an intact RNA editing site was 5 or fewer in most cases, giving a total of 10 serial G bases (5 + 5). In contrast, the number of G nucleotides inserted into the RNA editing site in O695 showed an atypical pattern, with six or fewer in most cases. This resulted in a total of 10 (4 + 6), suggesting the additional insertion of one more nongenomic G to the mRNA of the P gene of O695 compared with viruses carrying no mutations in the RNA editing site. Phylogenetic analysis reveals that mutations in the RNA editing site occur sporadically with various mutation patterns, suggesting that these mutations are routinely selected for during the life cycle of HPIV3.
- 11 February 2025
- Published by Wiley in Microbiology and Immunology
- Vol. 69 (4) , 220-228
A Clinical Isolate of Human Parainfluenza Virus 3 (Fukushima/O695/2019) Contains a Mutation in the Serial Guanosines in the RNA Editing Site of the P Gene and Produces an Atypical Number of Nongenomic Guanosine Insertions During RNA Editing
Human parainfluenza virus 3 (HPIV3) contains a purine‐rich RNA editing site, allowing multiple viral proteins to be produced from a single gene by the posttranscriptional addition of G nucleotides. The Fukushima/O695/2019 (O695) HPIV3 clinical isolate has a G‐to‐A substitution at the last position of five serial G residues in the RNA editing site. This study evaluates the effects of this substitution in the RNA editing site on the biological character of HPIV3. Our results show that O695 has slightly reduced viral replication compared with viruses with an intact RNA editing site. The number of G nucleotides inserted into the RNA editing site in HPIV3 isolates with an intact RNA editing site was 5 or fewer in most cases, giving a total of 10 serial G bases (5 + 5). In contrast, the number of G nucleotides inserted into the RNA editing site in O695 showed an atypical pattern, with six or fewer in most cases. This resulted in a total of 10 (4 + 6), suggesting the additional insertion of one more nongenomic G to the mRNA of the P gene of O695 compared with viruses carrying no mutations in the RNA editing site. Phylogenetic analysis reveals that mutations in the RNA editing site occur sporadically with various mutation patterns, suggesting that these mutations are routinely selected for during the life cycle of HPIV3.
- Open Access
- 12 January 2025
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 19 (1) , e70070
Temporal Trends in Respiratory Infection Epidemics Among Pediatric Inpatients Throughout the Course of the COVID‐19 Pandemic From 2018 to 2023 in Fukushima Prefecture, Japan
Background: Nonpharmaceutical interventions for coronavirus disease (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2, during the pandemic altered the epidemiology of respiratory viruses. This study aimed to determine the changes in respiratory viruses among children hospitalized from 2018 to 2023.Methods: Nasopharyngeal specimens were collected from children aged under 15 years with fever and/or respiratory symptoms admitted to a medical institution in Fukushima Prefecture between January 2018 and December 2023. Eighteen respiratory viruses were detected using real‐time reverse transcription‐polymerase chain reaction.Results: Overall, 1933 patients were included. Viruses were detected in 1377 (71.2%); of these, a single virus was detected in 906 (46.9%) and multiple viruses in 471 (24.3%). Among the viruses whose epidemics were temporarily suppressed, the epidemics of respiratory syncytial virus A and human parainfluenza virus type 3 (HPIV3) started earlier, and the epidemics of human metapneumovirus, HPIV1, and influenza A and C viruses resumed as behavioral restrictions for preventing COVID‐19 eased. The median age of children with airway infection was significantly higher in the postpandemic group than in the prepandemic group (18.0 months vs. 21.0 months, p < 0.01). The median age of children infected with HPIV3 and human rhinovirus was significantly higher in the postpandemic group than in the prepandemic group.Conclusions: Strengthening of nonpharmaceutical interventions changed the epidemic dynamics of pediatric infectious diseases, with a trend toward older hospitalized children. Continuous monitoring of pediatric infectious disease outbreaks in hospitalized children can help prepare for the emergence of future viruses and pandemics.
- 12 January 2025
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 19 (1) , e70070
Open AccessTemporal Trends in Respiratory Infection Epidemics Among Pediatric Inpatients Throughout the Course of the COVID‐19 Pandemic From 2018 to 2023 in Fukushima Prefecture, Japan
Background: Nonpharmaceutical interventions for coronavirus disease (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2, during the pandemic altered the epidemiology of respiratory viruses. This study aimed to determine the changes in respiratory viruses among children hospitalized from 2018 to 2023.Methods: Nasopharyngeal specimens were collected from children aged under 15 years with fever and/or respiratory symptoms admitted to a medical institution in Fukushima Prefecture between January 2018 and December 2023. Eighteen respiratory viruses were detected using real‐time reverse transcription‐polymerase chain reaction.Results: Overall, 1933 patients were included. Viruses were detected in 1377 (71.2%); of these, a single virus was detected in 906 (46.9%) and multiple viruses in 471 (24.3%). Among the viruses whose epidemics were temporarily suppressed, the epidemics of respiratory syncytial virus A and human parainfluenza virus type 3 (HPIV3) started earlier, and the epidemics of human metapneumovirus, HPIV1, and influenza A and C viruses resumed as behavioral restrictions for preventing COVID‐19 eased. The median age of children with airway infection was significantly higher in the postpandemic group than in the prepandemic group (18.0 months vs. 21.0 months, p < 0.01). The median age of children infected with HPIV3 and human rhinovirus was significantly higher in the postpandemic group than in the prepandemic group.Conclusions: Strengthening of nonpharmaceutical interventions changed the epidemic dynamics of pediatric infectious diseases, with a trend toward older hospitalized children. Continuous monitoring of pediatric infectious disease outbreaks in hospitalized children can help prepare for the emergence of future viruses and pandemics.
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70295
A case of Takayasu arteritis with advanced macrovascular lesions due to 6 years from onset to diagnosis
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70295
A case of Takayasu arteritis with advanced macrovascular lesions due to 6 years from onset to diagnosis
- Open Access
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70296
Impact of the COVID‐19 pandemic on RSV epidemiology in Fukushima, Japan
Background: The COVID‐19 pandemic that started in 2020 led to a significant reduction of many respiratory tract infections, including respiratory syncytial virus (RSV) infection. Methods: With the cooperation of all 16 pediatric inpatient facilities in Fukushima Prefecture, we actively investigated the total numbers of RSV hospitalizations and severe lower respiratory tract infections (LRTIs) requiring respiratory support during a 10‐year period from 2014 to 2023. In addition, the number of sentinel RSV reports was obtained. We compared the disease burden of RSV infection between the period of 2014 and 2019 (defined as pre‐pandemic) and that of 2021 to 2023 (defined as post‐pandemic). Results: The annual number of sentinel RSV reports per 10,000 children aged <5 years after the pandemic increased to 611 from 445 compared to the pre‐pandemic period. In contrast, the number of RSV‐related hospitalizations decreased from 175 to 104, and the number of severe RSV‐related LRTI cases decreased from 59 to 43. Analysis of sentinel reports and hospitalization numbers by age group showed a higher hospitalization rate in children aged <1 year compared to those aged ≥1 year. The age distribution of sentinel RSV reports was higher post‐pandemic than pre‐pandemic. Conclusion: Although the number of sentinel RSV reports increased after the pandemic, the number of RSV cases requiring hospitalization decreased compared to before the pandemic due mainly to an increase in the age of the infected children. This indicates the importance of preventing initial infection in children aged <1 year.
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70296
Open AccessImpact of the COVID‐19 pandemic on RSV epidemiology in Fukushima, Japan
Background: The COVID‐19 pandemic that started in 2020 led to a significant reduction of many respiratory tract infections, including respiratory syncytial virus (RSV) infection. Methods: With the cooperation of all 16 pediatric inpatient facilities in Fukushima Prefecture, we actively investigated the total numbers of RSV hospitalizations and severe lower respiratory tract infections (LRTIs) requiring respiratory support during a 10‐year period from 2014 to 2023. In addition, the number of sentinel RSV reports was obtained. We compared the disease burden of RSV infection between the period of 2014 and 2019 (defined as pre‐pandemic) and that of 2021 to 2023 (defined as post‐pandemic). Results: The annual number of sentinel RSV reports per 10,000 children aged <5 years after the pandemic increased to 611 from 445 compared to the pre‐pandemic period. In contrast, the number of RSV‐related hospitalizations decreased from 175 to 104, and the number of severe RSV‐related LRTI cases decreased from 59 to 43. Analysis of sentinel reports and hospitalization numbers by age group showed a higher hospitalization rate in children aged <1 year compared to those aged ≥1 year. The age distribution of sentinel RSV reports was higher post‐pandemic than pre‐pandemic. Conclusion: Although the number of sentinel RSV reports increased after the pandemic, the number of RSV cases requiring hospitalization decreased compared to before the pandemic due mainly to an increase in the age of the infected children. This indicates the importance of preventing initial infection in children aged <1 year.
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70244
Trends in pediatric bacterial meningitis incidence in Fukushima Prefecture, Japan, 1988–2024
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70244
Trends in pediatric bacterial meningitis incidence in Fukushima Prefecture, Japan, 1988–2024
- Open Access
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70208
Incidence trends and disease burden of respiratory syncytial virus (RSV) infection from 2014 to 2019 before the COVID‐19 pandemic in Fukushima, Japan
Background: The incidence trends and disease burden of pediatric respiratory syncytial virus (RSV) infection in Japan have yet to be fully elucidated. Methods: With the cooperation of all 16 pediatric inpatient facilities in Fukushima Prefecture, we prospectively investigated the numbers of hospitalizations due to lower respiratory tract infections (LRTIs) caused by RSV and severe LRTIs requiring respiratory support caused by RSV and other pathogens during a 6‐year period between 2014 and 19. In addition, the number of RSV infection cases at sentinel sites was obtained. Results: During the study period, there were 1117–1520 (average 1306) severe LRTI cases per year in Fukushima Prefecture, of which 23.7%–33.6% (average 30.6%) were due to RSV. The number of pediatric hospitalized patients with RSV infection ranged from 998 to 1426 per year (average 1177), and the number of RSV infection cases reported from sentinel sites in Fukushima Prefecture ranged from 2523 to 3477 per year (average 3005). A strong correlation was observed between the number of hospitalized patients and that reported from the sentinel sites. The annual incidence of RSV‐related LRTIs during the same period was estimated to be 174 cases per 10,000 children aged under 5 years, with 59 severe cases. Conclusion: The present study demonstrated that RSV infection was the leading cause of severe LRTIs in children in Fukushima Prefecture, accounting for approximately 30% of all cases. Furthermore, 1.7% of children under the age of 5 required hospitalization, highlighting the significant disease burden of RSV infection in this population.
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70208
Open AccessIncidence trends and disease burden of respiratory syncytial virus (RSV) infection from 2014 to 2019 before the COVID‐19 pandemic in Fukushima, Japan
Background: The incidence trends and disease burden of pediatric respiratory syncytial virus (RSV) infection in Japan have yet to be fully elucidated. Methods: With the cooperation of all 16 pediatric inpatient facilities in Fukushima Prefecture, we prospectively investigated the numbers of hospitalizations due to lower respiratory tract infections (LRTIs) caused by RSV and severe LRTIs requiring respiratory support caused by RSV and other pathogens during a 6‐year period between 2014 and 19. In addition, the number of RSV infection cases at sentinel sites was obtained. Results: During the study period, there were 1117–1520 (average 1306) severe LRTI cases per year in Fukushima Prefecture, of which 23.7%–33.6% (average 30.6%) were due to RSV. The number of pediatric hospitalized patients with RSV infection ranged from 998 to 1426 per year (average 1177), and the number of RSV infection cases reported from sentinel sites in Fukushima Prefecture ranged from 2523 to 3477 per year (average 3005). A strong correlation was observed between the number of hospitalized patients and that reported from the sentinel sites. The annual incidence of RSV‐related LRTIs during the same period was estimated to be 174 cases per 10,000 children aged under 5 years, with 59 severe cases. Conclusion: The present study demonstrated that RSV infection was the leading cause of severe LRTIs in children in Fukushima Prefecture, accounting for approximately 30% of all cases. Furthermore, 1.7% of children under the age of 5 required hospitalization, highlighting the significant disease burden of RSV infection in this population.
- Open Access
- 1 January 2025
- Published by Japanese Society for Pediatric Nephrology in Japanese journal of pediatric nephrology
- Vol. 38, cr.24-024
A 14-year-old girl diagnosed with systemic lupus erythematosus following the onset of peritonitis
全身性エリテマトーデス(systemic lupus erythematosus: SLE)の合併症のひとつにループス腹膜炎がある.SLEの活動期に一致して腹膜刺激症状などを呈する病態だが,小児例での報告はわずかである.症例は14歳女子.腹部膨満,下腿浮腫,腹痛を主訴に受診した.血液検査で低アルブミン血症,低ナトリウム血症,血小板減少を認め,精査加療目的に入院した.低補体血症を認めたが,dsDNA抗体や尿蛋白は陰性であった.画像検査では著明な腹水貯留を認めた.ステロイド治療により経時的に腹水は減少し,検査値の改善も得られた.その後腎生検にてループス腎炎(International Society of Nephrology/Renal Pathology Society [ISN/RPS])class III(A)を認め,SLEと診断した.ステロイドパルス療法,ヒドロキシクロロキン,ミコフェノール酸モフェチルによる治療を行い,寛解が得られた.本症例はSLE診断基準に合致しない部分もあり,診断に難渋した.早期診断のためには,ループス腹膜炎に対する理解と腎生検による評価が重要である.
- 1 January 2025
- Published by Japanese Society for Pediatric Nephrology in Japanese journal of pediatric nephrology
- Vol. 38, cr.24-024
Open AccessA 14-year-old girl diagnosed with systemic lupus erythematosus following the onset of peritonitis
全身性エリテマトーデス(systemic lupus erythematosus: SLE)の合併症のひとつにループス腹膜炎がある.SLEの活動期に一致して腹膜刺激症状などを呈する病態だが,小児例での報告はわずかである.症例は14歳女子.腹部膨満,下腿浮腫,腹痛を主訴に受診した.血液検査で低アルブミン血症,低ナトリウム血症,血小板減少を認め,精査加療目的に入院した.低補体血症を認めたが,dsDNA抗体や尿蛋白は陰性であった.画像検査では著明な腹水貯留を認めた.ステロイド治療により経時的に腹水は減少し,検査値の改善も得られた.その後腎生検にてループス腎炎(International Society of Nephrology/Renal Pathology Society [ISN/RPS])class III(A)を認め,SLEと診断した.ステロイドパルス療法,ヒドロキシクロロキン,ミコフェノール酸モフェチルによる治療を行い,寛解が得られた.本症例はSLE診断基準に合致しない部分もあり,診断に難渋した.早期診断のためには,ループス腹膜炎に対する理解と腎生検による評価が重要である.
- Open Access
- 17 August 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (4) , e0260622
Molecular Diversity of Human Respiratory Syncytial Virus before and during the COVID-19 Pandemic in Two Neighboring Japanese Cities
Understanding the molecular diversity of human respiratory syncytial viruses during pandemics caused by different viruses can provide insights that can guide public health decisions and vaccine development.
- 17 August 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (4) , e0260622
Open AccessMolecular Diversity of Human Respiratory Syncytial Virus before and during the COVID-19 Pandemic in Two Neighboring Japanese Cities
Understanding the molecular diversity of human respiratory syncytial viruses during pandemics caused by different viruses can provide insights that can guide public health decisions and vaccine development.